Article

Probabilistic approaches for classifying highly variable anti-SARS-CoV-2 antibody responses

2020-07-17

Abstract excerpt

Antibody responses vary widely between individuals 1 , complicating the correct classification of low-titer measurements using conventional assay cut-offs. We found all participants in a clinically diverse cohort of SARS-CoV-2 PCR+ individuals ( n =105) – and n= 33 PCR+ hospital staff – to have detectable IgG specific for pre-fusion-stabilized spike (S) glycoprotein trimers, while 98% of persons had IgG specific f...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7d296965-df92-5809-80dd-bfff3fbf9c37
DOI: 10.1101/2020.07.17.20155937

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Probabilistic approaches for classifying highly variable anti-SARS-CoV-2 antibody responsesDOI 10.1101/2020.07.17.20155937Read

Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody featuresSemantic proximity Read

Bead-assisted SARS-CoV-2 multi-antigen serological test allows effective identification of patientsSemantic proximity Read

Clinical and laboratory considerations: Determining an antibody-based composite correlate of risk for reinfection with SARS-CoV-2 or severe COVID-19Semantic proximity Read

Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody responseSemantic proximity Read

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standardSemantic proximity Read

Performance, Dynamic Change and Clinical Relevance of SARS-CoV-2 Antibody ResponsesSemantic proximity Read

Two-dimensional multiplexed assay for rapid and deep SARS-CoV-2 serology profiling and for machine learning prediction of neutralization capacitySemantic proximity Read

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes.Semantic proximity Read

SARS-CoV-2 antibody responses determine disease severity in COVID-19 infected individualsSemantic proximity Read

Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunitySemantic proximity Read

A translational multiplex serology approach to profile the prevalence of anti-SARS-CoV-2 antibodies in home-sampled bloodSemantic proximity Read

Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severitySemantic proximity Read